Home
News
Regional News
Diseases
Disease News
Healthcare Policies
Conferences
COVID-19
Contact
More
COVID19 drug updates | FDA EMA approved COVID19 drugs
COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine
COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers
European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19
Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief
WHO granted EUL to Covaxin; acclaims easy storage requirement
United Kingdom COVID19 News | Has Britain reached herd immunity?
France COVID-19 Updates | COVID-19 News in Europe
Is AstraZeneca and Oxford’s COVID vaccine safe? Australia prefers Pfizer vaccine
European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine
J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine
Sanofi and GSK to supply 72 million doses of the COVID-19 vaccine
Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’
FDA extended emergency use authorization of Veklury to all hospitalized patients
FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test
CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES
Gilead’s Veklury received conditional marketing authorization from the European Commission
Janssen’s COVID-19 vaccine trial to begin in second half of July
Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients
EMA allowed compassionate use of remdesivir to patients who were not on mechanical ventilation
PFIZER AND BIONTECH STARTS THE CLINICAL TRIALS OF COVID-19 VACCINE
FACTS ABOUT CHLOROQUINE TREATMENT FOR COVID-19
J&J announces lead vaccine for COVID-19, commits to provide one billion vaccines worldwide
NICE recommendation to manage symptoms of COVID-19
COVID-19 UPDATES
HOW CHINA IS RESPONSIBLE FOR COVID-19 OUTBREAK